Prevent an increase in the proportion of nontyphoidal Salmonella infections that are resistant to multiple drug classes — Data - Healthy People 2030

Status: Baseline only

Most Recent Data:
10.6 percent (2015-17)

Target:
10.6 percent

Desired Direction:
Maintains

Baseline:
10.6 percent of nontyphoidal Salmonella infections in humans were resistant to 3 or more drug classes in 2015-17

Show disparities data *

Show confidence interval (CI)

Show standard error (SE)

Confidence Interval (CI) not available Standard Error (SE) not available

Show disparities data *

**Non-typhoidal *Salmonella* from humans resistant to 3+ classes of antimicrobial agents**
(percent), **2015-17**
Population	2015-17
Total	10.6

Data Source: National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), CDC/NCEZID

#: Standard errors and confidence intervals are not available for this population group.

†: Target is not applicable for this demographic group.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

DNA: Data have not been analyzed.

DNC: Data for specific population not collected.

--- : Data are not available.